Pacific Biosciences of California, Inc.
PACB
$1.32
$0.043.13%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.70% | 98.06% | -1,802.70% | 37.42% | 75.81% |
| Total Depreciation and Amortization | 101.26% | -98.91% | -57.54% | -72.66% | -2,604.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -97.16% | -475.48% | 117.50% | -28.89% | 236.86% |
| Change in Net Operating Assets | -54.84% | 232.89% | -10.45% | 118.57% | 38.84% |
| Cash from Operations | -21.13% | -1.44% | 37.78% | 58.85% | 45.86% |
| Capital Expenditure | -182.73% | -119.08% | 46.75% | -89.07% | 62.81% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 61.13% | -123.80% | -55.07% | -15.54% | -67.01% |
| Cash from Investing | 58.49% | -20.73% | -55.31% | -18.05% | -67.10% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -26.65% | -- | 80.91% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -26.65% | 100.00% | 80.91% | 100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 215.85% | -335.73% | 130.78% | 107.71% | -118.26% |